Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center.

Background And Purpose: Inhibition of the neonatal Fc receptor (FcRn) for IgG is a promising new therapeutic strategy for antibody-mediated disorders. We report our real-life experience with efgartigimod (EFG) in 19 patients with generalized myasthenia gravis (gMG) along a clinical follow-up of 14 months.

Methods: EFG was administered according to the GENERATIVE protocol (consisting of a Fixed period of two treatment cycles [given 1 month apart] of four infusions at weekly intervals, followed by a Flexible period of re-cycling in case of worsening).

Stereodivergent access to all four stereoisomers of chiral tetrahydrobenzo[][1,4]oxazepines, through highly diastereoselective multicomponent Ugi-Joullié reaction.

Starting from easily accessible chiral enantiopure 1,2-amino alcohols and salicylaldehydes, a concise route to cyclic imines has been developed. These chiral cyclic imines undergo a highly diastereoselective Ugi-Joullié reaction to give tetrahydrobenzo[][1,4]oxazepines with the introduction of up to 4 diversity inputs. The isomer may also be attained, thanks to a thermodynamically controlled base catalysed epimerization.

2-(Hydroxyimino)aldehydes: Photo- and Physicochemical Properties of a Versatile Functional Group for Monomer Design.

In the context of our research on stimuli-responsive polymers bearing the 2-(hydroxyimino)aldehyde (HIA) group, we have explored the photochemical behavior and physicochemical properties of a number of HIAs. Interpretation of the experimental data is supported by quantum mechanical calculations. HIAs are expected to undergo photoisomerization, chelate metal ions, yield hydrogen-bonded dimers or oligomers, exhibit relatively low pK s, and form >C=NO radicals through OH hydrogen abstraction or oxidation of the oximate ion.